Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 24, 2020, titled "The Company and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF.".
Press Release Dec 24 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Aurobindo Pharma
- Press Release Dec 09 2020
- Press Release Nov 11 2020
- Press Release Oct 22 2020
- Press Release Sep 15 2020
Later from Aurobindo Pharma
- Press Release Feb 19 2021
- Press Release Aug 27 2021
- Press Release Sep 22 2021
- Press Release Sep 29 2021
- Press Release Dec 28 2021
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma